Skip to main content
. 2019 Jul 24;60(4):415–419. doi: 10.1002/mus.26629

Table 1.

Patient characteristics

Patient Sex Age, y Disease duration, mo First symptoms Clinical findings Clinical phenotype Improvement after treatment
1 W 50 34 Weakness right hand Weakness and atrophy both hands MMN Increased muscle strength both hands
2 M 61 3 Weakness both legs Symmetric distal > proximal weakness legs, low tendon reflexes, reduced vibration sense feet, postural tremor CIDP Increased muscle strength legs
3 M 66 6 Weakness both hands Symmetric distal > proximal weakness and atrophy arms, proximal weakness legs, reduced vibration sense feet, absent tendon reflexes CIDP Increased muscle strength arms and legs
4 M 75 2 Paraesthesia feet Symmetric distal > proximal weakness legs, reduced vibration sense lower legs and hands, absent tendon reflexes, tremor and sensory ataxia CIDP Increased muscle strength legs, reduced sensory ataxia
5 M 58 2 Paraesthesia feet Symmetric proximal weakness arms and legs, absent tendon reflexes, postural tremor CIDP Increased muscle strength arms and legs
6 M 75 24 Paraesthesia feet Symmetric hypoesthesia lower legs, absent tendon reflexes, sensory ataxia CIDP Reduced sensory ataxia, gain in balance

Abbreviations: CIDP, chronic inflammatory demyelinating polyneuropathy; M, man; MMN, multifocal motor neuropathy; W, woman.